Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""IMMUNOSUPPRESSION"" wg kryterium: Temat


Starter badań:

Tytuł :
A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine.
Autorzy :
Moutsopoulos HM; Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens and Academy of Athens, Athens, Greece. Electronic address: .
Pokaż więcej
Źródło :
Journal of autoimmunity [J Autoimmun] 2021 Jul; Vol. 121, pp. 102649. Date of Electronic Publication: 2021 May 01.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19*/immunology
COVID-19*/prevention & control
COVID-19 Vaccines*/immunology
COVID-19 Vaccines*/therapeutic use
Immunosuppression*
Rheumatic Diseases*/immunology
Rheumatic Diseases*/therapy
Vaccination*
SARS-CoV-2/*immunology
Cytokines/isolation & purification ; Humans ; Pneumococcal Vaccines/immunology ; Pneumococcal Vaccines/therapeutic use
Czasopismo naukowe
Tytuł :
Evaluation of Quantiferon®-Monitor as a biomarker of immunosuppression and predictor of infection in lung transplant recipients.
Autorzy :
Gardiner BJ; Department of Infectious Disease, Alfred Health and Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Lee SJ; Department of Infectious Disease, Alfred Health and Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Cristiano Y; Department of Respiratory Medicine & Lung Transplantation, Alfred Health and Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Levvey BJ; Department of Respiratory Medicine & Lung Transplantation, Alfred Health and Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Sullivan LC; Department of Respiratory Medicine & Lung Transplantation, Alfred Health and Central Clinical School, Monash University, Melbourne, Victoria, Australia.; Department of Microbiology & Immunology, University of Melbourne and Peter Doherty Institute for Infection & Immunity, Melbourne, Victoria, Australia.
Snell GI; Department of Respiratory Medicine & Lung Transplantation, Alfred Health and Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Peleg AY; Department of Infectious Disease, Alfred Health and Central Clinical School, Monash University, Melbourne, Victoria, Australia.; Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, Victoria, Australia.
Westall GP; Department of Respiratory Medicine & Lung Transplantation, Alfred Health and Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło :
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2021 Jun; Vol. 23 (3), pp. e13550. Date of Electronic Publication: 2021 Jan 05.
Typ publikacji :
Journal Article
MeSH Terms :
Immunosuppression*
Transplant Recipients*
Biomarkers ; Graft Rejection ; Humans ; Lung ; Lung Transplantation ; Prospective Studies
Czasopismo naukowe
Tytuł :
Immunosuppression for Liver Retransplantation: Babel Revisited.
Autorzy :
Peters AL; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH.; Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Tremblay S; Department of Surgery, Division of Transplantation, University of Cincinnati, Cincinnati, OH.; Department of Environmental Health, Division of Epidemiology, University of Cincinnati, Cincinnati, OH.
Alloway RR; Department of Internal Medicine, Division of Nephrology, University of Cincinnati, Cincinnati, OH.
Woodle ES; Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2021 Aug 01; Vol. 105 (8), pp. 1658-1659.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Graft Survival*
Immunosuppression*
Liver/surgery ; Reoperation
Czasopismo naukowe
Tytuł :
Severe COVID-19: Immunosuppression or Hyperinflammation?
Autorzy :
Liu Y; Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.; Clinical Research Center of Hubei Critical Care Medicine, Hubei, China.
Li Y; Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.; Clinical Research Center of Hubei Critical Care Medicine, Hubei, China.
Xu D; Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.; Clinical Research Center of Hubei Critical Care Medicine, Hubei, China.
Zhang J; Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.; Clinical Research Center of Hubei Critical Care Medicine, Hubei, China.
Peng Z; Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.; Clinical Research Center of Hubei Critical Care Medicine, Hubei, China.
Pokaż więcej
Źródło :
Shock (Augusta, Ga.) [Shock] 2021 Aug 01; Vol. 56 (2), pp. 188-199.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Immune Tolerance*
Immunosuppression*
Inflammation*
COVID-19/*immunology
COVID-19/epidemiology ; Humans ; Pandemics
Czasopismo naukowe
Tytuł :
Risk Factors and Management of Leukopenia After Kidney Transplantation: A Single-Center Experience.
Autorzy :
Henningsen M; Department of Medicine IV, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
Jaenigen B; Department of General and Digestive Surgery, Section of Transplant Surgery, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
Zschiedrich S; Department of Medicine IV, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
Pisarski P; Department of General and Digestive Surgery, Section of Transplant Surgery, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
Walz G; Department of Medicine IV, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
Schneider J; Department of Medicine IV, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany. Electronic address: .
Pokaż więcej
Źródło :
Transplantation proceedings [Transplant Proc] 2021 Jun; Vol. 53 (5), pp. 1589-1598. Date of Electronic Publication: 2021 May 18.
Typ publikacji :
Evaluation Study; Journal Article
MeSH Terms :
Immunosuppression/*methods
Immunosuppressive Agents/*administration & dosage
Kidney Transplantation/*adverse effects
Leukopenia/*drug therapy
Postoperative Complications/*drug therapy
Adult ; Case-Control Studies ; Cytomegalovirus Infections/drug therapy ; Cytomegalovirus Infections/immunology ; Cytomegalovirus Infections/therapy ; Drug Substitution ; Female ; Graft Rejection/immunology ; Graft Rejection/prevention & control ; Humans ; Immunosuppression/adverse effects ; Leukopenia/immunology ; Leukopenia/prevention & control ; Male ; Middle Aged ; Postoperative Complications/immunology ; Postoperative Complications/prevention & control ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
The Changing Landscape of Pneumocystis Jiroveci Infection in Kidney Transplant Recipients: Single-Center Experience of Late-Onset Pneumocystis Pneumonia.
Autorzy :
Marinaki S; Nephrology and Kidney Transplantation Clinic, Laiko Hospital, National and Kapodistrian University of Athens, Faculty of Medicine, Athens, Greece.
Vallianou K; Nephrology and Kidney Transplantation Clinic, Laiko Hospital, National and Kapodistrian University of Athens, Faculty of Medicine, Athens, Greece. Electronic address: .
Melexopoulou C; Nephrology and Kidney Transplantation Clinic, Laiko Hospital, National and Kapodistrian University of Athens, Faculty of Medicine, Athens, Greece.
Lionaki S; 2nd Department of Internal Medicine, Attikon Hospital, National and Kapodistrian University of Athens, Faculty of Medicine, Athens, Greece.
Darema M; Nephrology and Kidney Transplantation Clinic, Laiko Hospital, National and Kapodistrian University of Athens, Faculty of Medicine, Athens, Greece.
Lambrou P; Pneumonology Department, Laiko Hospital, Athens, Greece.
Boletis I; Nephrology and Kidney Transplantation Clinic, Laiko Hospital, National and Kapodistrian University of Athens, Faculty of Medicine, Athens, Greece.
Pokaż więcej
Źródło :
Transplantation proceedings [Transplant Proc] 2021 Jun; Vol. 53 (5), pp. 1576-1582. Date of Electronic Publication: 2021 May 04.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Pneumocystis carinii*
Immunosuppression/*adverse effects
Kidney Transplantation/*adverse effects
Pneumonia, Pneumocystis/*immunology
Postoperative Complications/*microbiology
Adult ; Aged ; Female ; Humans ; Immunosuppression/methods ; Male ; Middle Aged ; Pneumonia, Pneumocystis/chemically induced ; Pneumonia, Pneumocystis/drug therapy ; Postoperative Complications/chemically induced ; Postoperative Complications/drug therapy ; Retrospective Studies ; Time Factors ; Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use
Czasopismo naukowe
Tytuł :
Targeted regulation of lymphocytic ER stress response with an overall immunosuppression to alleviate allograft rejection.
Autorzy :
Shi Y; College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang, 310058, PR China.
Lu Y; College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang, 310058, PR China.
Zhu C; College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang, 310058, PR China.
Luo Z; College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang, 310058, PR China.
Li X; College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang, 310058, PR China.
Liu Y; College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang, 310058, PR China.
Jiang M; College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang, 310058, PR China.
Liu X; College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang, 310058, PR China.
Luo L; College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang, 310058, PR China.
Du Y; College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang, 310058, PR China.
You J; College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang, 310058, PR China. Electronic address: .
Pokaż więcej
Źródło :
Biomaterials [Biomaterials] 2021 May; Vol. 272, pp. 120757. Date of Electronic Publication: 2021 Mar 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Graft Rejection*/prevention & control
Immunosuppression*
Protein-Serine-Threonine Kinases*
Allografts ; Animals ; CD8-Positive T-Lymphocytes ; Endoplasmic Reticulum Stress ; Endoribonucleases ; Mice
Czasopismo naukowe
Tytuł :
Frontline Science: OX40 agonistic antibody reverses immune suppression and improves survival in sepsis.
Autorzy :
Unsinger J; Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Walton AH; Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Blood T; Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Tenney DJ; Bristol Myers Squibb, Leads Discovery & Optimization, Lawrenceville, New Jersey, USA.
Quigley M; Bristol Myers Squibb, Oncology Discovery Biology, Redwood City, California, USA.; Current affiliation, Gilead Sciences, Inc., Foster City, California, USA.
Drewry AM; Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Hotchkiss RS; Department of Anesthesiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Pokaż więcej
Źródło :
Journal of leukocyte biology [J Leukoc Biol] 2021 Apr; Vol. 109 (4), pp. 697-708. Date of Electronic Publication: 2020 Aug 17.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunosuppression*
Antibodies/*therapeutic use
Receptors, OX40/*agonists
Sepsis/*drug therapy
Sepsis/*immunology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Animals ; CD4-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/immunology ; Cecum/pathology ; Critical Illness ; Female ; Granulocytes/metabolism ; Humans ; Hypersensitivity, Delayed/immunology ; Interferon-gamma/metabolism ; Ligation ; Lymphocyte Count ; Macrophages/metabolism ; Male ; Mice, Inbred C57BL ; Middle Aged ; Punctures ; Receptors, OX40/metabolism ; Survival Analysis ; Tumor Necrosis Factor-alpha/metabolism ; Young Adult
Czasopismo naukowe
Tytuł :
Induction Immunosuppression and Renal Outcomes in Adult Heart Transplantation.
Autorzy :
Diaz-Castrillon CE; Division of Cardiac Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Huckaby LV; Division of Cardiac Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Hickey G; Division of Cardiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Sultan I; Division of Cardiac Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Kilic A; Division of Cardiac Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. Electronic address: .
Pokaż więcej
Źródło :
The Journal of surgical research [J Surg Res] 2021 Mar; Vol. 259, pp. 14-23. Date of Electronic Publication: 2020 Dec 02.
Typ publikacji :
Journal Article
MeSH Terms :
Heart Failure/*surgery
Heart Transplantation/*adverse effects
Immunosuppression/*adverse effects
Postoperative Complications/*epidemiology
Practice Patterns, Physicians'/*statistics & numerical data
Renal Insufficiency/*epidemiology
Adult ; Aged ; Confounding Factors, Epidemiologic ; Female ; Glomerular Filtration Rate/physiology ; Graft Rejection/immunology ; Graft Rejection/prevention & control ; Heart Failure/complications ; Heart Failure/mortality ; Humans ; Immunosuppression/methods ; Immunosuppression/standards ; Immunosuppression/statistics & numerical data ; Male ; Middle Aged ; Postoperative Complications/etiology ; Postoperative Complications/physiopathology ; Postoperative Complications/therapy ; Practice Guidelines as Topic ; Practice Patterns, Physicians'/standards ; Preoperative Period ; Renal Dialysis/statistics & numerical data ; Renal Insufficiency/etiology ; Renal Insufficiency/physiopathology ; Renal Insufficiency/therapy ; Retrospective Studies ; Risk Factors ; Young Adult
Czasopismo naukowe
Tytuł :
Atovaquone Suppresses Triple-Negative Breast Tumor Growth by Reducing Immune-Suppressive Cells.
Autorzy :
Gupta N; Department of Biomedical Sciences, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.; Department of Immunotherapeutics and Biotechnology, Center for Tumor Immunology, and Targeted Cancer Therapy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA.
Gaikwad S; Department of Immunotherapeutics and Biotechnology, Center for Tumor Immunology, and Targeted Cancer Therapy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA.
Kaushik I; Department of Immunotherapeutics and Biotechnology, Center for Tumor Immunology, and Targeted Cancer Therapy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA.
Wright SE; Department of Biomedical Sciences, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.; Department of Internal Medicine, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.
Markiewski MM; Department of Immunotherapeutics and Biotechnology, Center for Tumor Immunology, and Targeted Cancer Therapy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA.
Srivastava SK; Department of Biomedical Sciences, Texas Tech University Health Sciences Center, Amarillo, TX 79106, USA.; Department of Immunotherapeutics and Biotechnology, Center for Tumor Immunology, and Targeted Cancer Therapy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 May 13; Vol. 22 (10). Date of Electronic Publication: 2021 May 13.
Typ publikacji :
Journal Article
MeSH Terms :
Immunosuppression*
Anti-Infective Agents/*pharmacology
Antigen Presentation/*immunology
Atovaquone/*pharmacology
Myeloid-Derived Suppressor Cells/*immunology
T-Lymphocytes, Regulatory/*immunology
Triple Negative Breast Neoplasms/*drug therapy
Animals ; Apoptosis ; Cell Proliferation ; Cytokines/metabolism ; Female ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Inbred NOD ; Mice, SCID ; Myeloid-Derived Suppressor Cells/drug effects ; T-Lymphocytes, Regulatory/drug effects ; Triple Negative Breast Neoplasms/metabolism ; Triple Negative Breast Neoplasms/pathology ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Low-dose radiotherapy for COVID 19: A radioimmunological perspective.
Autorzy :
Kumar R; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India.
Haresh KP; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India.
Sharma DN; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi; Department of Radiation Oncology, National Cancer Institute, All India Institute of Medical Sciences, Jhajjar, Haryana, India.
Gupta A; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India.
Gupta S; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India.
Vellaiyan S; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India.
Rath GK; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi; Department of Radiation Oncology, National Cancer Institute, All India Institute of Medical Sciences, Jhajjar, Haryana, India.
Pokaż więcej
Źródło :
Journal of cancer research and therapeutics [J Cancer Res Ther] 2021 Apr-Jun; Vol. 17 (2), pp. 295-302.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19/*radiotherapy
Cytokine Release Syndrome/*radiotherapy
Immunosuppression/*methods
SARS-CoV-2/*immunology
COVID-19/complications ; COVID-19/immunology ; COVID-19/virology ; Clinical Decision-Making ; Cytokine Release Syndrome/immunology ; Cytokine Release Syndrome/virology ; Humans ; Immunosuppression/adverse effects ; Radiotherapy Dosage ; Severity of Illness Index ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies - A Danish population-based cohort study.
Autorzy :
Attauabi M; Gastrounit, Medical Section, Hvidovre University Hospital, Hvidovre, Denmark; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, University of Copenhagen, Hvidovre Hospital, Denmark; Department of Gastroenterology and Hepatology, Herlev Hospital, University of Copenhagen, Denmark. Electronic address: .
Seidelin JB; Department of Gastroenterology and Hepatology, Herlev Hospital, University of Copenhagen, Denmark.
Felding OK; Gastrounit, Medical Section, Hvidovre University Hospital, Hvidovre, Denmark; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, University of Copenhagen, Hvidovre Hospital, Denmark.
Wewer MD; Gastrounit, Medical Section, Hvidovre University Hospital, Hvidovre, Denmark; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, University of Copenhagen, Hvidovre Hospital, Denmark.
Vinther Arp LK; Gastrounit, Medical Section, Hvidovre University Hospital, Hvidovre, Denmark; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, University of Copenhagen, Hvidovre Hospital, Denmark.
Sarikaya MZ; Gastrounit, Medical Section, Hvidovre University Hospital, Hvidovre, Denmark; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, University of Copenhagen, Hvidovre Hospital, Denmark.
Egeberg A; Department of Dermatology and Allergy, Herlev and Gentofte Hospital, Copenhagen, Denmark.
Vladimirova N; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Center of Head and Orthopedics, Rigshospitalet, Glostrup, Denmark.
Bendtsen F; Gastrounit, Medical Section, Hvidovre University Hospital, Hvidovre, Denmark; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, University of Copenhagen, Hvidovre Hospital, Denmark.
Burisch J; Gastrounit, Medical Section, Hvidovre University Hospital, Hvidovre, Denmark; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, University of Copenhagen, Hvidovre Hospital, Denmark.
Pokaż więcej
Źródło :
Journal of autoimmunity [J Autoimmun] 2021 Mar; Vol. 118, pp. 102613. Date of Electronic Publication: 2021 Feb 12.
Typ publikacji :
Clinical Trial; Journal Article; Multicenter Study
MeSH Terms :
COVID-19 Nucleic Acid Testing*
Immunosuppression*
SARS-CoV-2*
COVID-19/*drug therapy
Immunosuppressive Agents/*administration & dosage
Adult ; Age Factors ; Aged ; COVID-19/diagnosis ; COVID-19/epidemiology ; Denmark/epidemiology ; Female ; Humans ; Inflammation/diagnosis ; Inflammation/epidemiology ; Inflammation/therapy ; Male ; Middle Aged ; Risk Factors
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe
Tytuł :
The transplant cohort of the German center for infection research (DZIF Tx-Cohort): study design and baseline characteristics.
Autorzy :
Karch A; Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany. .; German Center for Infection Research, Hannover-Braunschweig Site, Brunswick, Germany. .
Schindler D; Department of Nephrology, Klinikum rechts der Isar of the Technical University Munich, Munich, Germany.; German Center for Infection Research, Munich Site, Munich, Germany.
Kühn-Steven A; German Center for Infection Research, Munich Site, Munich, Germany.; German Research Center for Environmental Health, Helmholtz Zentrum München, Munich, Germany.
Blaser R; German Center for Infection Research, Munich Site, Munich, Germany.; Institute of Medical Informatics, Statistics and Epidemiology, Technical University Munich, Munich, Germany.
Kuhn KA; German Center for Infection Research, Munich Site, Munich, Germany.; Institute of Medical Informatics, Statistics and Epidemiology, Technical University Munich, Munich, Germany.
Sandmann L; German Center for Infection Research, Hannover-Braunschweig Site, Brunswick, Germany.; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School (MHH), Hannover, Germany.
Sommerer C; German Center for Infection Research, Heidelberg Site, Heidelberg, Germany.; Nierenzentrum Heidelberg, Heidelberg, Germany.
Guba M; German Center for Infection Research, Munich Site, Munich, Germany.; Department of General, Visceral and Transplantation Surgery, University Hospital, LMU Munich, Munich, Germany.
Heemann U; Department of Nephrology, Klinikum rechts der Isar of the Technical University Munich, Munich, Germany.; German Center for Infection Research, Munich Site, Munich, Germany.
Strohäker J; German Center for Infection Research, Tübingen Site, Tübingen, Germany.; University Hospital for General, Visceral and Transplant Surgery, Tübingen, Germany.
Glöckner S; German Center for Infection Research, Hannover-Braunschweig Site, Brunswick, Germany.; Epidemiology, Helmholtz Center for Infection Research Braunschweig, Brunswick, Germany.
Mikolajczyk R; Institute for Medical Epidemiology, Biometry and Informatics, Medical Faculty, Martin-Luther University Halle-Wittenberg, Halle, Germany.
Busch DH; German Center for Infection Research, Munich Site, Munich, Germany.; Institute for Medical Microbiology, Immunology and Hygiene (MIH), Technical University of Munich, Munich, Germany.
Schulz TF; German Center for Infection Research, Hannover-Braunschweig Site, Brunswick, Germany.; Institute of Virology, Hannover Medical School (MHH), Hannover, Germany.
Pokaż więcej
Corporate Authors :
for the Transplant Cohort of the German Center for Infection Research (DZIF Transplant Cohort) Consortium
Źródło :
European journal of epidemiology [Eur J Epidemiol] 2021 Feb; Vol. 36 (2), pp. 233-241. Date of Electronic Publication: 2021 Jan 25.
Typ publikacji :
Journal Article
MeSH Terms :
Biological Specimen Banks*
Immunosuppression*
Organ Transplantation*
Postoperative Complications*
Research Design*
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Bacterial Infections ; Child ; Child, Preschool ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł :
A Comparison of Immunosuppression Regimens in Hand, Face, and Kidney Transplantation.
Autorzy :
Rifkin WJ; Hansjörg Wyss Department of Plastic Surgery, NYU Langone Health, New York, New York.
Manjunath AK; Hansjörg Wyss Department of Plastic Surgery, NYU Langone Health, New York, New York.
Kantar RS; Hansjörg Wyss Department of Plastic Surgery, NYU Langone Health, New York, New York.
Jacoby A; Hansjörg Wyss Department of Plastic Surgery, NYU Langone Health, New York, New York.
Kimberly LL; Hansjörg Wyss Department of Plastic Surgery, NYU Langone Health, New York, New York.
Gelb BE; Department of Surgery, NYU Langone Health, New York, New York.
Diaz-Siso JR; Hansjörg Wyss Department of Plastic Surgery, NYU Langone Health, New York, New York.
Rodriguez ED; Hansjörg Wyss Department of Plastic Surgery, NYU Langone Health, New York, New York. Electronic address: .
Pokaż więcej
Źródło :
The Journal of surgical research [J Surg Res] 2021 Feb; Vol. 258, pp. 17-22. Date of Electronic Publication: 2020 Sep 23.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Kidney Transplantation*
Vascularized Composite Allotransplantation*
Immunosuppression/*methods
Immunosuppressive Agents/*administration & dosage
Humans ; Immunosuppression/trends ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Operational tolerance in intestinal transplantation.
Autorzy :
Kroemer A; Center for Translational Transplant Medicine, MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Georgetown University Medical Center, Washington, District of Columbia, USA.
Khan K; Center for Translational Transplant Medicine, MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Georgetown University Medical Center, Washington, District of Columbia, USA.
Kaufman SS; Center for Translational Transplant Medicine, MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Georgetown University Medical Center, Washington, District of Columbia, USA.
Kang J; Center for Translational Transplant Medicine, MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Georgetown University Medical Center, Washington, District of Columbia, USA.
Weiner J; Center for Translational Transplant Medicine, MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Georgetown University Medical Center, Washington, District of Columbia, USA.
Duttargi A; Center for Translational Transplant Medicine, MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Georgetown University Medical Center, Washington, District of Columbia, USA.
Belyayev L; Center for Translational Transplant Medicine, MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Georgetown University Medical Center, Washington, District of Columbia, USA.
Ashokkumar C; The Hillman Center for Pediatric Transplantation, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Sindhi R; The Hillman Center for Pediatric Transplantation, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Timofeeva OA; Department of Pathology and Laboratory Medicine, Georgetown University Medical Center, Washington, District of Columbia, USA.
Zasloff M; Center for Translational Transplant Medicine, MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Georgetown University Medical Center, Washington, District of Columbia, USA.
Matsumoto CS; Center for Translational Transplant Medicine, MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Georgetown University Medical Center, Washington, District of Columbia, USA.
Fishbein TM; Center for Translational Transplant Medicine, MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Georgetown University Medical Center, Washington, District of Columbia, USA.
Pokaż więcej
Źródło :
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2021 Feb; Vol. 21 (2), pp. 876-882. Date of Electronic Publication: 2020 Aug 30.
Typ publikacji :
Case Reports; Research Support, N.I.H., Extramural
MeSH Terms :
Immunosuppression*
Immunosuppressive Agents*
Graft Rejection/etiology ; Graft Survival ; Humans ; Immune Tolerance ; Intestines ; Transplantation Tolerance ; Transplantation, Homologous
Raport
Tytuł :
The Impact of Immunosuppression and Autoimmune Disease on Severe Outcomes in Patients Hospitalized with COVID-19.
Autorzy :
Monreal E; Department of Neurology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Crta Colmenar Viejo, km 9,100, 28034, Madrid, Spain. .
Sainz de la Maza S; Department of Neurology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Crta Colmenar Viejo, km 9,100, 28034, Madrid, Spain.
Fernández-Velasco JI; Department of Immunology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Madrid, Spain.
Natera-Villalba E; Department of Neurology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Crta Colmenar Viejo, km 9,100, 28034, Madrid, Spain.
Rita CG; Department of Immunology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Madrid, Spain.
Rodríguez-Jorge F; Department of Neurology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Crta Colmenar Viejo, km 9,100, 28034, Madrid, Spain.
Beltrán-Corbellini Á; Department of Neurology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Crta Colmenar Viejo, km 9,100, 28034, Madrid, Spain.
Iturrieta-Zuazo I; Department of Immunology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Madrid, Spain.
Rodríguez de Santiago E; Department of Gastroenterology and Hepatology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Madrid, Spain.
Espiño M; Department of Immunology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Madrid, Spain.
de Andrés A; Department of Immunology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Madrid, Spain.
Fortún J; Department of Infectious Diseases, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Madrid, Spain.
Barbero E; Department of Pneumology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Madrid, Spain.
Vázquez M; Department of Rheumatology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Madrid, Spain.
Fernández Lucas M; Department of Nephrology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Madrid, Spain.
Manzano L; Department of Internal Medicine, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Madrid, Spain.
Montero-Errasquín B; Department of Geriatrics, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Madrid, Spain.
Costa-Frossard L; Department of Neurology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Crta Colmenar Viejo, km 9,100, 28034, Madrid, Spain.
Masjuan J; Department of Neurology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Crta Colmenar Viejo, km 9,100, 28034, Madrid, Spain.
Villar LM; Department of Immunology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, IRYCIS, Madrid, Spain.
Pokaż więcej
Corporate Authors :
COVID-HRC group
Źródło :
Journal of clinical immunology [J Clin Immunol] 2021 Feb; Vol. 41 (2), pp. 315-323. Date of Electronic Publication: 2020 Nov 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Health Impact Assessment*
SARS-CoV-2*
Autoimmune Diseases/*complications
Autoimmune Diseases/*epidemiology
COVID-19/*complications
COVID-19/*epidemiology
Immunosuppression/*adverse effects
Aged ; Autoimmune Diseases/metabolism ; Autoimmune Diseases/therapy ; Biomarkers ; COVID-19/diagnosis ; COVID-19/metabolism ; Combined Modality Therapy ; Comorbidity ; Cytokines/metabolism ; Female ; Hospitalization ; Humans ; Immunosuppression/methods ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Trauma Severity Indices ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Operative management of colonic diverticular disease in the setting of immunosuppression: A systematic review and meta-analysis.
Autorzy :
McKechnie T; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada; Division of General Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada. Electronic address: .
Lee Y; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada; Division of General Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada. Electronic address: .
Kruse C; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada. Electronic address: .
Qiu Y; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada. Electronic address: .
Springer JE; Division of General Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada. Electronic address: .
Doumouras AG; Division of General Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada; Division of General Surgery, Department of Surgery, St. Joseph Healthcare, Hamilton, Ontario, Canada. Electronic address: .
Hong D; Division of General Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada; Division of General Surgery, Department of Surgery, St. Joseph Healthcare, Hamilton, Ontario, Canada. Electronic address: .
Eskicioglu C; Division of General Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada; Division of General Surgery, Department of Surgery, St. Joseph Healthcare, Hamilton, Ontario, Canada. Electronic address: .
Pokaż więcej
Źródło :
American journal of surgery [Am J Surg] 2021 Jan; Vol. 221 (1), pp. 72-85. Date of Electronic Publication: 2020 Jul 08.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Immunosuppression*
Diverticulitis, Colonic/*surgery
Humans ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Multispecific Platinum(IV) Complex Deters Breast Cancer via Interposing Inflammation and Immunosuppression as an Inhibitor of COX-2 and PD-L1.
Autorzy :
Jin S; State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, P. R. China.
Muhammad N; State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, P. R. China.; School of Chemistry, Sun Yat-Sen University, Guangzhou, 510275, P. R. China.
Sun Y; State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, 210023, P. R. China.
Tan Y; State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, 210023, P. R. China.
Yuan H; State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, P. R. China.
Song D; State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, P. R. China.
Guo Z; State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, P. R. China.; Chemistry and Biomedicine Innovation Center, Nanjing University, Nanjing, 210023, P. R. China.
Wang X; State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, 210023, P. R. China.
Pokaż więcej
Źródło :
Angewandte Chemie (International ed. in English) [Angew Chem Int Ed Engl] 2020 Dec 14; Vol. 59 (51), pp. 23313-23321. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunosuppression*
Antineoplastic Agents/*pharmacology
Breast Neoplasms/*drug therapy
Cyclooxygenase 2 Inhibitors/*pharmacology
Inflammation/*drug therapy
Organoplatinum Compounds/*pharmacology
Antineoplastic Agents/chemical synthesis ; Antineoplastic Agents/chemistry ; B7-H1 Antigen/antagonists & inhibitors ; B7-H1 Antigen/immunology ; Breast Neoplasms/diagnosis ; Breast Neoplasms/immunology ; Cell Cycle Checkpoints/drug effects ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cyclooxygenase 2/immunology ; Cyclooxygenase 2 Inhibitors/chemical synthesis ; Cyclooxygenase 2 Inhibitors/chemistry ; Drug Screening Assays, Antitumor ; Female ; Humans ; Inflammation/immunology ; Organoplatinum Compounds/chemical synthesis ; Organoplatinum Compounds/chemistry
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies